| Pseudomonas putida KT2440 is HV1 certified, not GRAS LFC Kampers, RJM Volkers, VAP Martins dos Santos Microbial biotechnology 12 (5), 845-848, 2019 | 80 | 2019 |
| Vaccination of carp against SVCV with an oral DNA vaccine or an insect cells-based subunit vaccine CWE Embregts, D Rigaudeau, L Tacchi, GP Pijlman, L Kampers, T Veselý, ... Fish & Shellfish Immunology 85, 66-77, 2019 | 37 | 2019 |
| In silico-guided engineering of Pseudomonas putida towards growth under micro-oxic conditions LFC Kampers, RGA Van Heck, S Donati, E Saccenti, RJM Volkers, ... Microbial Cell Factories 18, 1-14, 2019 | 27 | 2019 |
| From innovation to application: bridging the valley of death in industrial biotechnology LFC Kampers, E Asin-Garcia, PJ Schaap, A Wagemakers, ... Trends in Biotechnology 39 (12), 1240-1242, 2021 | 26 | 2021 |
| A metabolic and physiological design study of Pseudomonas putida KT2440 capable of anaerobic respiration LFC Kampers, JJ Koehorst, RJA van Heck, M Suarez-Diez, AJM Stams, ... BMC microbiology 21, 1-15, 2021 | 24 | 2021 |
| Navigating the Valley of Death: Perceptions of Industry and Academia on Production Platforms and Opportunities in Biotechnology LFC Kampers, E Asin-Garcia, PJ Schaap, A Wagemakers, ... EFB Bioeconomy Journal 2, 100033, 2022 | 8 | 2022 |
| The Application of Evidence-Based Medicine in Individualized Medicine P Van de Vliet, T Sprenger, LFC Kampers, J Makalowski, V Schirrmacher, ... Biomedicines 11 (7), 1793, 2023 | 3 | 2023 |
| Navigating the Valley of Death: perceptions of industry and academia on production platforms and opportunities LFC Kampers, EA Garcia, PJ Schaap, A Wagemakers, ... bioRxiv, 2020.05. 04.075770, 2020 | 3 | 2020 |
| Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients. SW Van Gool, P Van de Vliet, LFC Kampers, J Kosmal, T Sprenger, ... Methods in Cell Biology 183, 51-113, 2023 | 1 | 2023 |
| Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached? SW Van Gool, J Makalowski, LFC Kampers, P Van de Vliet, T Sprenger, ... Translational Cancer Research 12 (8), 2224, 2023 | 1 | 2023 |
| MONITORING GBM PATIENT HEALTH-RELATED QUALITY OF LIFE AND QUALITY ADJUSTED LIFE MONTHS DURING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY USING EQ-5D-5L P Van de Vliet, J Makalowski, L Kampers, T Sprenger, V Schirrmacher, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| MULTIPHASE COMBINED TREATMENT, INCLUDING INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY FOR ADULTS WITH GBM: SINGLE INSTITUTE REAL WORLD MEDICAL DATA IN THE LIGHT OF CLINICAL TRIAL … S Van Gool, P Van de Vliet, L Kampers, J Makalowski, T Sprenger, ... NEURO-ONCOLOGY 25, 2023 | | 2023 |
| IMMU-02. CMV-EXPANDED T-CELLS IN GLIOBLASTOMA PATIENTS: TRANSLATIONAL RESEARCH LFC Kampers, G Rajabpour, M Bitar, V Schirrmacher, W Stücker, ... Neuro-Oncology 25 (Suppl 1), i49, 2023 | | 2023 |
| Exploring the Impact of Tensions in Stakeholder Norms on Designing for Value Change: The Case of Biosafety in Industrial Biotechnology E Asin-Garcia, Z Robaey, LFC Kampers, VAP Martins dos Santos Science and Engineering Ethics 29 (2), 9, 2023 | | 2023 |
| Exploring the Impact of Tensions in Stakeholder Norms on Designing for Value Change: The Case of Biosafety in Industrial Biotechnology VAPM dos Santos, LFC Kampers, Z Robaey, E Asin-Garcia | | 2023 |
| Microbial hosts engineered for increased tolerance to temperature shifts LFC Kampers, JM Volkers, PJ Schaap, VAPM dos Santos US Patent App. 17/291,620, 2022 | | 2022 |
| 1243 3D Bioprinting to Fabricate Living Microalgal Materials M Pavlovich, LFC Kampers, E Asin-Garcia, PJ Schaap, A Wagemakers, ... Biotechnology 39 (12), 2021 | | 2021 |
| A Rational Design of Pseudomonas putida KT2440 capable of Anaerobic Respiration LFC Kampers, JJ Koehorst, RGA van Heck, M Suarez-Diez, AJM Stams, ... | | 2020 |
| Microbial lifestyle engineering LFC Kampers PQDT-Global, 2020 | | 2020 |
